SK bioscience

‘Chuseok’ symbolizes gratitude and unity. At SK bioscience, we embrace these values globally and collaborate closely with our partners to create a better tomorrow. Just as families gather during this meaningful holiday and make wishes upon the full moon, we strive to contribute to global public health through vaccines, providing a healthier future for all. #SKbioscience #FromPreventionToCure #Chuseok #KoreanThanksgivingDay

📢 We're pleased to announce that we held a a topping-out ceremony and a safety prayer ritual for our Songdo Global R&PD Center on Monday! The topping-out ceremony traditionally marks the point when the framework of a building is nearly complete, and the highest structural beam is installed. It symbolizes the completion of the frame construction and is conducted to wish for the safe completion of the remaining work. We plan to relocate our headquarters and research facilities upon completion. Read more: https://lnkd.in/gTiGNrri

[Myth vs Truth] Vaccination is a responsible act for your own health as well as health of your community. Recently, we've seen a resurgence of COVID-19. But many people are still misinformed about the COVID-19 vaccine. Let's take a look at some misconceptions about COVID-19 vaccines. COVID-19 vaccines are effective in building immunity to many variants, not just COVID-19. #SKbioscience #FromPreventionToCure #MythvsTruth #Vaccine 

COVID-19 is on the rise again. With the emergence of new virus strains, the threat of COVID-19 is growing. Let's stay alert and prevent it! #SKbioscience #FromPreventionToCure #COVID19 #Vaccine

SK bioscience DNA, a series of stories about SK bioscience told by our Caring Professionals, is back! Our sixth guest is Eunseung Shin, supervisor in the DP1. We asked about his work, atmosphere in the team, what he does and what he thinks about SK bioscience. Eunseung says that SK bioscience is “like a Field". Let's find out more about his story. #SKbioscience #FromPreventionToCure #Interview #SKbioscienceDNA

We're pleased to welcome KLOCKE GRUPPE and IDT Biologika to SK bioscience! Our partners visited our laboratory in Headquarters, our manufacturing plant L HOUSE in Andong, and our Songdo Global R&PD Center, which is currently under construction. We look forward to our continuous partnership built through transforming our relationship from a partner to a family! SK bioscience has signed an agreement with Klocke Group, a German biopharmaceutical group, to acquire the controlling stake in Klocke Group’s affiliate, IDT Biologika, one of the top 10 global vaccine contract manufacturers. last June.

We're pleased to announce that SK bioscience and CEPI (Coalition for Epidemic Preparedness Innovations) hosted the 'Celebrating Partnership for Pandemic Preparedness: CEPI-SK bioscience Reception' in Yeoui-do, Seoul on August 29. About 80 global health experts and leaders gathered at the event, organized to discuss a strategic partnership between CEPI and the Republic of Korea across in all sectors to prepare for and response to the next pandemic. The occasion was attended by the distinguished representatives such as Professor Jane Halton, Chair of the CEPI board, Dr. Richard Hatchett, CEO of CEPI (Coalition for Epidemic Preparedness Innovations), Jaeyong Ahn, CEO of SK bioscience, and Dr. Jerome Kim, Director General of the International Vaccine Institute (IVI). The event was also attended by representatives from the Korean government and health authorities such as National Assembly member Honorable Yoon Kim; Hyejin Kim, Deputy Minister for Planning and Coordination, Ministry of Health and Welfare; Jonghan Park, Director General, Development Cooperation Bureau, Ministry of Foreign Affairs; and Youngmee Jee, Commissioner of the Korea Disease Control and Prevention Agency (KDCA).

We're honored to welcome members of CEPI (Coalition for Epidemic Preparedness Innovations)’s Investors Council to our headquarters in Seongnam, S. Korea! We deeply value our strong partnership with CEPI (Coalition for Epidemic Preparedness Innovations) as we continue our journey toward our mission of promoting global health-from prevention to cure. Together, we’re committed to enabling equitable access to vaccines by developing and manufacturing life-saving vaccines for all over the world for global pandemic preparedness.

The COVID-19 pandemic, which we thought was under control, has recently shown signs of resurgence in several countries. South Korea, as well as the United States and United Kingdom, have seen an increase in the number of cases of KP.3, a variant of COVID-19. Research shows that this variant is not highly lethal, but it spreads rapidly. For this reason, caution is advised. Getting vaccinated is essential to fight the COVID-19 pandemic. Vaccination is both your best weapon and shield to protect yourself and your community from COVID-19. #SKbioscience #FromPreventionToCure #COVID19 #KP3 #Vaccinate

Curious about how vaccines are made? 💉 It starts with rigorous trials and safety checks, followed by precise manufacturing and packaging. Strict cold chain management ensures their effectiveness as well as a save transport. Continuous monitoring guarantees ongoing safety and efficacy even after reaching the patients. This meticulous process makes vaccines safe and reliable, thereby protecting global health. 🛡 For more details, check out the cartoon below!